Home > ARTICLES > POLAND’S LARGEST PRODUCER OF MEDICINES

POLAND’S LARGEST PRODUCER OF MEDICINES

Polpharma is the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. It actively operates in the markets of Central and Eastern Europe, the Caucasus and Central Asia. For over 80 years the company has enjoyed the trust of patients, healthcare professionals and business partners.

It belongs to the top 20 generic drug manufacturers in the world. The company employs about 7,500 people in Poland and on international markets. It runs 7 manufacturing plants in Poland, Russia and Kazakhstan, 7 research and development centres as well as sales and marketing organizations in Poland, Russia, Lithuania, Latvia, Ukraine, Belarus, the Czech Republic, Slovakia, Bulgaria, Romania, Azerbaijan, Kazakhstan, Uzbekistan and Vietnam. Polpharma Group’s portfolio includes about 600 products.
Polpharma manufactures a wide range of prescription drugs and pharmaceuticals for in-patient care. It has a leading share in key therapeutic areas in Poland. The company specializes in pharmaceutical preparations used in cardiology, gastroenterology and neurology. Over-the-counter medications (OTC) account for a significant part of its product portfolio. In addition, its offer includes dietary supplements, medical devices, cosmetics and phytopharmaceuticals. Polpharma is also the largest Polish manufacturer of pharmaceutical substances, which are available in over 60 countries on 6 continents.
Polpharma’s strength lies in a combination of long-standing experience, the highest management standards and modern production technologies. All of its products comply with the international standards of Good Manufacturing Practice.
The company spends significant resources on developing new products awaited by patients. It belongs to the largest investors in Poland in terms of research and development. In the Index of Polish Business Patriotism published by Fundacja Patriotyzmu Gospodarczego (The Foundation of Economic Patriotism) and the “Rzeczpospolita” daily, Polpharma was ranked third in the R&D category.
Polpharma rapidly develops also in the area of biotechnological drugs. The company has established one of the most modern laboratories in Europe in the Gdańsk Science and Technology Park, where it conducts research on biosimilars.
Polpharma’s motto is “People helping people.” It follows a social responsibility strategy based on the following key pillars: serving the patients and the community, ethical conduct of business, innovation and advancing knowledge. Polpharma attaches importance to harmonious coexistence with the natural environment and makes efforts to minimize the environmental footprint of its manufacturing activities. The company organizes numerous educational campaigns and programs promoting healthy lifestyle.
Established in 2001, Polpharma Scientific Foundation finances research projects in the field of pharmacy and medicine. As many as 64 research teams have received grants since the beginning of its operation. The Foundation also offers a scholarship program for postgraduate students from medical universities.